Yahoo
NYSE USD

Agilent Technologies, Inc. (A)

174.87 -6.28 (-3.47%)
At close: October 30 at 4:00:03 PM EDT
171.27 -3.60 (-2.06%)
After hours: October 30 at 4:35:03 PM EDT
Trade A on Coinbase
Chart Range Bar
Loading chart for A

What's happening with A?

38m ago
Powered by Yahoo Scout

Agilent Technologies is broadening its role in energy-materials research, digital pathology, and genomics workflows. Recent coverage presents long-term growth opportunities, but valuation and slower historical growth create competing signals for investors.

Powered by Yahoo Scout
  • Previous Close 181.15
  • Open 180.98
  • Bid 169.00 x 10000
  • Ask 180.00 x 40000
  • Day's Range 173.38 - 180.80
  • 52 Week Range 108.35 - 182.99
  • Volume 2,756,259
  • Avg. Volume 2,224,655
  • Market Cap (intraday) 49.307B
  • Beta (5Y Monthly) 1.21
  • PE Ratio (TTM) 35.76
  • EPS (TTM) 4.89
  • Earnings Date Nov 23, 2026
  • Forward Dividend & Yield 1.02 (0.56%)
  • 1y Target Est 182.05
  • Morningstar Rating Rating available with Stock Picks access

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and other custom services. This segment also offers consumables, including gas chromatography and liquid chromatography columns, sample preparation products, custom chemistries, and various laboratory supplies; software and informatics solutions comprising software for instrument control, data acquisition, data analysis, secure storage of results, and laboratory information and workflow management; and OpenLab laboratory software, an open software platform that enables customers to capture, analyze, and share scientific data throughout the lab and across the enterprise. In addition, it provides automated sample preparation solutions, such as liquid handling, plate management, consumables, and scheduling software. The Applied Markets segment offers products in the areas of gas chromatography, mass spectrometry, spectroscopy, vacuum technology, and remarketed instruments. It markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

www.agilent.com

18,200

Full Time Employees

October 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

A
29.48%
S&P 500 (^GSPC)
10.73%

1-Year Return

A
22.90%
S&P 500 (^GSPC)
11.11%

3-Year Return

A
76.75%
S&P 500 (^GSPC)
81.91%

5-Year Return

A
15.08%
S&P 500 (^GSPC)
64.59%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 1.88B
Earnings 362M
Profit Margin 19.28%

Q4

FY25

Q1

FY26

Q2

FY26

Q3

FY26

0
500M
1B
2B
18.0%
20.0%
22.0%

Analyst Insights

View More

Analyst Price Targets

155.00 Low
182.05 Average
174.87 Current
200.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 10/26/2026
Analyst Deutsche Bank
Rating Action Initiated
Rating Buy
Price Action Announces
Price Target 190

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    19.53%

  • Return on Assets (ttm)

    8.63%

  • Return on Equity (ttm)

    20.97%

  • Revenue (ttm)

    7.37B

  • Net Income Avi to Common (ttm)

    1.44B

  • Diluted EPS (ttm)

    4.89

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.76B

  • Total Debt/Equity (mrq)

    56.34%

  • Levered Free Cash Flow (ttm)

    1.06B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: